Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Ursodeoxycholic Acid Drug Product Market Report for Period 2018 till 2026

Single User: $2999
Multiple User: $3999
Enterprise User: $4999


Report Summary:

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.

Scope of the Report:
This report focuses on the Ursodeoxycholic Acid Drug Product in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Capsule
Tablet

Market Segment by Applications, can be divided into
Gallstone
Hepatopathy
Biliary Disease
Other

There are 15 Chapters to deeply display the global Ursodeoxycholic Acid Drug Product market.

Chapter 1, to describe Ursodeoxycholic Acid Drug Product Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Ursodeoxycholic Acid Drug Product, with sales, revenue, and price of Ursodeoxycholic Acid Drug Product, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Ursodeoxycholic Acid Drug Product, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Ursodeoxycholic Acid Drug Product market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Ursodeoxycholic Acid Drug Product sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Ursodeoxycholic Acid Drug Product Introduction
1.2 Market Analysis by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Market Analysis by Applications
1.3.1 Gallstone
1.3.2 Hepatopathy
1.3.3 Biliary Disease
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Dr. Falk Pharma
2.1.1 Business Overview
2.1.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Daewoong Pharmaceutical
2.2.1 Business Overview
2.2.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva
2.3.1 Business Overview
2.3.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Teva Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Epic Pharma
2.4.1 Business Overview
2.4.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Epic Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mitsubishi Tanabe Pharma
2.5.1 Business Overview
2.5.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lannett
2.6.1 Business Overview
2.6.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Lannett Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Mylan
2.7.1 Business Overview
2.7.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Mylan Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bruschettini
2.8.1 Business Overview
2.8.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Bruschettini Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Impax
2.9.1 Business Overview
2.9.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Impax Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shanghai Pharma
2.10.1 Business Overview
2.10.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Grindeks
2.11.1 Business Overview
2.11.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Grindeks Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Ursodeoxycholic Acid Drug Product Market Competition, by Manufacturer
3.1 Global Ursodeoxycholic Acid Drug Product Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Ursodeoxycholic Acid Drug Product Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Ursodeoxycholic Acid Drug Product Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Ursodeoxycholic Acid Drug Product Manufacturer Market Share in 2017
3.4.2 Top 5 Ursodeoxycholic Acid Drug Product Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Ursodeoxycholic Acid Drug Product Market Analysis by Regions
4.1 Global Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Regions
4.1.1 Global Ursodeoxycholic Acid Drug Product Sales by Regions (2013-2018)
4.1.2 Global Ursodeoxycholic Acid Drug Product Revenue by Regions (2013-2018)
4.2 North America Ursodeoxycholic Acid Drug Product Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Ursodeoxycholic Acid Drug Product Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Ursodeoxycholic Acid Drug Product Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales, Revenue and Growth Rate (2013-2018)
5 North America Ursodeoxycholic Acid Drug Product by Countries, Type, Application and Manufacturers
5.1 North America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Countries
5.1.1 North America Ursodeoxycholic Acid Drug Product Sales by Countries (2013-2018)
5.1.2 North America Ursodeoxycholic Acid Drug Product Revenue by Countries (2013-2018)
5.1.3 United States Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
5.1.4 Canada Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
5.1.5 Mexico Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
5.2 North America Ursodeoxycholic Acid Drug Product Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Ursodeoxycholic Acid Drug Product Sales by Manufacturers (2016-2017)
5.2.2 North America Ursodeoxycholic Acid Drug Product Revenue by Manufacturers (2016-2017)
5.3 North America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Ursodeoxycholic Acid Drug Product Sales and Sales Share by Type (2013-2018)
5.3.2 North America Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Type (2013-2018)
5.4 North America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Ursodeoxycholic Acid Drug Product Sales and Sales Share by Application (2013-2018)
5.4.2 North America Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Application (2013-2018)
6 Europe Ursodeoxycholic Acid Drug Product by Countries, Type, Application and Manufacturers
6.1 Europe Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Countries
6.1.1 Europe Ursodeoxycholic Acid Drug Product Sales by Countries (2013-2018)
6.1.2 Europe Ursodeoxycholic Acid Drug Product Revenue by Countries (2013-2018)
6.1.3 Germany Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
6.1.4 UK Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
6.1.5 France Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
6.1.6 Russia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
6.1.7 Italy Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
6.2 Europe Ursodeoxycholic Acid Drug Product Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Ursodeoxycholic Acid Drug Product Sales by Manufacturers (2016-2017)
6.2.2 Europe Ursodeoxycholic Acid Drug Product Revenue by Manufacturers (2016-2017)
6.3 Europe Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Ursodeoxycholic Acid Drug Product Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Ursodeoxycholic Acid Drug Product Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Ursodeoxycholic Acid Drug Product by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Ursodeoxycholic Acid Drug Product Revenue by Countries (2013-2018)
7.1.3 China Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
7.1.4 Japan Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
7.1.5 Korea Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
7.1.6 India Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Ursodeoxycholic Acid Drug Product Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Application (2013-2018)
8 South America Ursodeoxycholic Acid Drug Product by Countries, Type, Application and Manufacturers
8.1 South America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Countries
8.1.1 South America Ursodeoxycholic Acid Drug Product Sales by Countries (2013-2018)
8.1.2 South America Ursodeoxycholic Acid Drug Product Revenue by Countries (2013-2018)
8.1.3 Brazil Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
8.1.4 Argentina Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
8.1.5 Colombia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
8.2 South America Ursodeoxycholic Acid Drug Product Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Ursodeoxycholic Acid Drug Product Sales by Manufacturers (2016-2017)
8.2.2 South America Ursodeoxycholic Acid Drug Product Revenue by Manufacturers (2016-2017)
8.3 South America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Ursodeoxycholic Acid Drug Product Sales and Sales Share by Type (2013-2018)
8.3.2 South America Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Type (2013-2018)
8.4 South America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Ursodeoxycholic Acid Drug Product Sales and Sales Share by Application (2013-2018)
8.4.2 South America Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Ursodeoxycholic Acid Drug Product by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Ursodeoxycholic Acid Drug Product Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
9.1.4 UAE Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
9.1.5 Egypt Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
9.1.7 South Africa Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Ursodeoxycholic Acid Drug Product Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Ursodeoxycholic Acid Drug Product Revenue and Revenue Share by Application (2013-2018)
10 Global Ursodeoxycholic Acid Drug Product Market Segment by Type
10.1 Global Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Ursodeoxycholic Acid Drug Product Sales and Market Share by Type (2013-2018)
10.1.2 Global Ursodeoxycholic Acid Drug Product Revenue and Market Share by Type (2013-2018)
10.2 Capsule Sales Growth and Price
10.2.1 Global Capsule Sales Growth (2013-2018)
10.2.2 Global Capsule Price (2013-2018)
10.3 Tablet Sales Growth and Price
10.3.1 Global Tablet Sales Growth (2013-2018)
10.3.2 Global Tablet Price (2013-2018)
11 Global Ursodeoxycholic Acid Drug Product Market Segment by Application
11.1 Global Ursodeoxycholic Acid Drug Product Sales Market Share by Application (2013-2018)
11.2 Gallstone Sales Growth (2013-2018)
11.3 Hepatopathy Sales Growth (2013-2018)
11.4 Biliary Disease Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Ursodeoxycholic Acid Drug Product Market Forecast (2018-2023)
12.1 Global Ursodeoxycholic Acid Drug Product Sales, Revenue and Growth Rate (2018-2023)
12.2 Ursodeoxycholic Acid Drug Product Market Forecast by Regions (2018-2023)
12.2.1 North America Ursodeoxycholic Acid Drug Product Market Forecast (2018-2023)
12.2.2 Europe Ursodeoxycholic Acid Drug Product Market Forecast (2018-2023)
12.2.3 Asia-Pacific Ursodeoxycholic Acid Drug Product Market Forecast (2018-2023)
12.2.4 South America Ursodeoxycholic Acid Drug Product Market Forecast (2018-2023)
12.2.5 Middle East and Africa Ursodeoxycholic Acid Drug Product Market Forecast (2018-2023)
12.3 Ursodeoxycholic Acid Drug Product Market Forecast by Type (2018-2023)
12.3.1 Global Ursodeoxycholic Acid Drug Product Sales Forecast by Type (2018-2023)
12.3.2 Global Ursodeoxycholic Acid Drug Product Market Share Forecast by Type (2018-2023)
12.4 Ursodeoxycholic Acid Drug Product Market Forecast by Application (2018-2023)
12.4.1 Global Ursodeoxycholic Acid Drug Product Sales Forecast by Application (2018-2023)
12.4.2 Global Ursodeoxycholic Acid Drug Product Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 39963

Category: 16

Published date: 2018-05-23 07:41:53

Number of Pages: 101

Publisher Name: GIR

Over all Rating: 85 % (Average of Ratings provided by clients)